Prakash Jagtap

Inotek Pharmaceuticals Corporation

$6,029,479

Attributed

$6,029,479

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $982.5K · FY2011–17

$1M$750K$500K$250K$0

'11

'12

'13

'14

'15

'16

'17

Funding mix

By agency

NIH$6,029,479 · 12

By mechanism

R44$3,449,199 · 2

R43$2,580,280 · 10

Top collaborators

No co-investigators on record.

Most similar at Inotek Pharmaceuticals Corporation

Same institution · by research overlap

Andrew L Salzman$19,918,828
Garry John Southan$13,828,224
Kanneganti Murthy$5,565,701

Others in their field

Top investigators on “Clinically Relevant”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$347,663,527
Chanza Baytop · Westat, Inc.$271,217,917
Lawrence Corey · Fred Hutchinson Cancer Center$225,946,688
Barton F Haynes · Duke University$218,783,682

Research focus

Clinically RelevantInjuryTissuesSmall MoleculeBaseDoseMedicalSmall Business Innovation Research GrantSafetyIn VivoReactionRouteDrug Design /Synthesis /ProductionPlasmaProductionOxidation-ReductionCatalystPeroxonitriteMimeticsPharmacologic SubstanceAnimal ModelRattusExcisionLabel